Work

Feasibility Study of a Dose Dense Induction Regimen of High Dose Cytarabine (HiDAC) and Gemtuzumab Ozogamicin (Mylotarg™) for Newly Diagnosed Elderly Patients with Acute Myeloid Leukemia.

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.4610.4610

Authors: Arati V. Rao, David A. Rizzieri, Joseph O. Moore, Carlos DeCastro, Louis F. Diehl, Amy P. Abernethy, McLean Jordan, Patty Davis, Emily Edmonds, Jon P. Gockerman

Institution: Duke Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2566768564

FWCI: 0.195

Cites:

Cited by: 1

Related to: 10